Recently, a research team led by Prof. WANG Junfeng at the High Magnetic Field Laboratory, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed an innovative ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
New findings from the DIRECT PLUS, 18-month-long lifestyle intervention trial underscores the potential to observe and signify alterations of MRI-assessed liver fat with proteomics according to new ...
This prospective study included 135 patients (median age, 67 years; 66 women) who underwent MRI-guided SBRT for liver metastases across seven international centres between April 2019 and April 2023.
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
Investigators at Cedars Sinai analyzed long-term health outcomes, liver MRI scans, and blood proteins, finding new evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results